CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
Sang-Uk Park, Seung-Jun Lee, Moosang Kim
Korean J Ophthalmol. 2014;28(4):306-313.   Published online July 22, 2014
DOI: https://doi.org/10.3341/kjo.2014.28.4.306

Excel Download

Intravitreal Anti-vascular Endothelial Growth Factor versus Observation in Acute Central Serous Chorioretinopathy: One-year Results
Korean Journal of Ophthalmology. 2014;28(4):306   Crossref logo
Link1 Link2 Link3

Combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy
Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;251(1):403-404   Crossref logo
Link1 Link2 Link3

Intravitreal anti-vascular endothelial growth factor combined with half-fluence photodynamic therapy for choroidal neovascularization in chronic central serous chorioretinopathy
Eye. 2016;30(6):805-811   Crossref logo
Link1 Link2 Link3

Photodynamic therapy and anti-vascular endothelial growth factor for acute central serous chorioretinopathy: a systematic review and meta-analysis
Eye. 2015;30(1):15-22   Crossref logo
Link1 Link2 Link3

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
. 2021;   Crossref logo
Link1 Link2

Type one macular neovascularization in central serous chorioretinopathy: Short-term response to anti-vascular endothelial growth factor therapy
Eye. 2021;   Crossref logo
Link1 Link2 Link3

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
. 2020;   Crossref logo
Link1 Link2

One-year results of half-dose versus one-third-dose photodynamic therapy in chronic or recurrent central serous chorioretinopathy
. 2020;   Crossref logo
Link1 Link2

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;249(8):1159-1166   Crossref logo
Link1 Link2 Link3

Single-session combined photodynamic therapy with verteporfin and intravitreal anti-vascular endothelial growth factor therapy for chronic central serous chorioretinopathy: a pilot study at 12-month follow-up
Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;251(1):401-402   Crossref logo
Link1 Link2 Link3